These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 23495770)

  • 1. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
    Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
    Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
    Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
    Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
    Busse A; Asemissen A; Nonnenmacher A; Ochsenreither S; Fusi A; Braun F; Stather D; Schmittel A; Miller K; Thiel E; Keilholz U
    J Immunother; 2011 Jan; 34(1):113-9. PubMed ID: 21150720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
    Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
    van der Vliet HJ; Koon HB; Yue SC; Uzunparmak B; Seery V; Gavin MA; Rudensky AY; Atkins MB; Balk SP; Exley MA
    Clin Cancer Res; 2007 Apr; 13(7):2100-8. PubMed ID: 17404092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
    Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
    Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
    Porta C; Bonomi L; Lillaz B; Paglino C; Rovati B; Imarisio I; Morbini P; Villa C; Danova M; Mensi M; Rovereto B
    Anticancer Res; 2007; 27(1A):165-73. PubMed ID: 17352228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype of peripheral blood natural killer cells and IL-10 serum levels in relation to Helicobacter pylori status.
    Rudnicka K; Matusiak A; Miszczyk E; Rudnicka W; Tenderenda M; Chmiela M
    APMIS; 2013 Sep; 121(9):806-13. PubMed ID: 23758061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
    Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
    Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.
    Velilla PA; Shata MT; Lages CS; Ying J; Fichtenbaum CJ; Chougnet C
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):52-61. PubMed ID: 18275348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
    Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
    Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of immunological parameters on the effectiveness of systemic and loco-regional immunotherapy in disseminated renal carcinoma].
    Granov AM; Molchanov OE; Karelin MI; Shkol'nik MI; Krotova OA
    Vopr Onkol; 2009; 55(5):580-5. PubMed ID: 20020653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.